0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Competent Cells- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Published Date: August 2025
|
Report Code: QYRE-Auto-2G9608
Home | Market Reports | Science
Global Competent Cells Market Insights and Forecast to 2028
BUY CHAPTERS

Competent Cells- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Code: QYRE-Auto-2G9608
Report
August 2025
Pages:145
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Competent Cells- Market Size

The global market for Competent Cells was estimated to be worth US$ 2382 million in 2024 and is forecast to a readjusted size of US$ 4456 million by 2031 with a CAGR of 9.5% during the forecast period 2025-2031.

Competent Cells- Market

Competent Cells- Market

Competent cells are bacteria which can accept extra-chromosomal DNA or plasmids. Cells can be made competent in several ways. One such way is to "shock" it, which involves cooling the bacteria in a Calcium Chloride bath at 0 degrees Celsius, then quickly heating it to around 47 degrees Celsius for approximately 90 seconds (too long will denature the cell membrane, killing the bacteria). The calcium chloride ions neutralize the repulsion between the negatively charged phospholipid heads of the cell membrane and the negatively charged phosphate groups on the DNA. The quick heat shock creates a thermal gradient which, in turn, creates a draft leading into the cell, allowing extra-chromosomal DNA (such as plasmids) to enter the cell, allowing the bacterium to be genetically modifed.
Global Competent Cells key players include Beijing TransGen Biotech, Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, etc. Global top four manufacturers hold a share nearly 30%.
North America is the largest market, with a share about 10%, followed by Asia-Pacific and Europe, both have a share about 20 percent.
In terms of product, Chemically Competent Cells is the largest segment, with a share nearly 65%. And in terms of application, the largest application is Protein Expression, followed by Subcloning & Routine Cloning, Phage Display Library Construction, Toxic/Unstable DNA Cloning, etc.
This report aims to provide a comprehensive presentation of the global market for Competent Cells, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Competent Cells by region & country, by Type, and by Application.
The Competent Cells market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Competent Cells.
Market Segmentation

Scope of Competent Cells- Market Report

Report Metric Details
Report Name Competent Cells- Market
Forecasted market size in 2031 US$ 4456 million
CAGR 9.5%
Forecasted years 2025 - 2031
Segment by Type
  • Chemically Competent Cells
  • Electrocompetent Cells
Segment by Application
  • Subcloning & Routine Cloning
  • Phage Display Library Construction
  • Toxic/Unstable DNA Cloning
  • High-Throughput Cloning
  • Protein Expression
  • Mutagenesis
  • Single-Stranded DNA Production
  • Bacmid Creation
  • Cre-Lox Recombination (PIR1/PIR2)
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, Takara Bio, Promega Corporation, Beijing TransGen Biotech, GeneScript Corporation, Yeastern Biotech, New England Biolabs, QIAGEN N.V., OriGene Technologies, Lucigen, Zymo Research, Bio-Rad Laboratories, Bioline, Delphi Genetics, IBA GmBH, Cell Applications, BioDynamics Laboratory, Scarab Genomics, GCC Biotech, SMOBIO Technology, Edge BioSystems
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Competent Cells company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Competent Cells in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Competent Cells in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Competent Cells- Market size in 2031?

Ans: The Competent Cells- Market size in 2031 will be US$ 4456 million.

What is the market share of major companies in Competent Cells- Market?

Ans: Global top four manufacturers hold a share nearly 30%.

What is the Competent Cells- Market share by type?

Ans: In terms of product, Chemically Competent Cells is the largest segment, with a share nearly 65%.

Who are the main players in the Competent Cells- Market report?

Ans: The main players in the Competent Cells- Market are Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, Takara Bio, Promega Corporation, Beijing TransGen Biotech, GeneScript Corporation, Yeastern Biotech, New England Biolabs, QIAGEN N.V., OriGene Technologies, Lucigen, Zymo Research, Bio-Rad Laboratories, Bioline, Delphi Genetics, IBA GmBH, Cell Applications, BioDynamics Laboratory, Scarab Genomics, GCC Biotech, SMOBIO Technology, Edge BioSystems

What are the Application segmentation covered in the Competent Cells- Market report?

Ans: The Applications covered in the Competent Cells- Market report are Subcloning & Routine Cloning, Phage Display Library Construction, Toxic/Unstable DNA Cloning, High-Throughput Cloning, Protein Expression, Mutagenesis, Single-Stranded DNA Production, Bacmid Creation, Cre-Lox Recombination (PIR1/PIR2)

What are the Type segmentation covered in the Competent Cells- Market report?

Ans: The Types covered in the Competent Cells- Market report are Chemically Competent Cells, Electrocompetent Cells

1 Market Overview
1.1 Competent Cells Product Introduction
1.2 Global Competent Cells Market Size Forecast (2020-2031)
1.3 Competent Cells Market Trends & Drivers
1.3.1 Competent Cells Industry Trends
1.3.2 Competent Cells Market Drivers & Opportunity
1.3.3 Competent Cells Market Challenges
1.3.4 Competent Cells Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Competent Cells Players Revenue Ranking (2024)
2.2 Global Competent Cells Revenue by Company (2020-2025)
2.3 Key Companies Competent Cells Manufacturing Base Distribution and Headquarters
2.4 Key Companies Competent Cells Product Offered
2.5 Key Companies Time to Begin Mass Production of Competent Cells
2.6 Competent Cells Market Competitive Analysis
2.6.1 Competent Cells Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by Competent Cells Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Competent Cells as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Chemically Competent Cells
3.1.2 Electrocompetent Cells
3.2 Global Competent Cells Sales Value by Type
3.2.1 Global Competent Cells Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Competent Cells Sales Value, by Type (2020-2031)
3.2.3 Global Competent Cells Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Subcloning & Routine Cloning
4.1.2 Phage Display Library Construction
4.1.3 Toxic/Unstable DNA Cloning
4.1.4 High-Throughput Cloning
4.1.5 Protein Expression
4.1.6 Mutagenesis
4.1.7 Single-Stranded DNA Production
4.1.8 Bacmid Creation
4.1.9 Cre-Lox Recombination (PIR1/PIR2)
4.2 Global Competent Cells Sales Value by Application
4.2.1 Global Competent Cells Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Competent Cells Sales Value, by Application (2020-2031)
4.2.3 Global Competent Cells Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
5.1 Global Competent Cells Sales Value by Region
5.1.1 Global Competent Cells Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Competent Cells Sales Value by Region (2020-2025)
5.1.3 Global Competent Cells Sales Value by Region (2026-2031)
5.1.4 Global Competent Cells Sales Value by Region (%), (2020-2031)
5.2 North America
5.2.1 North America Competent Cells Sales Value, 2020-2031
5.2.2 North America Competent Cells Sales Value by Country (%), 2024 VS 2031
5.3 Europe
5.3.1 Europe Competent Cells Sales Value, 2020-2031
5.3.2 Europe Competent Cells Sales Value by Country (%), 2024 VS 2031
5.4 Asia Pacific
5.4.1 Asia Pacific Competent Cells Sales Value, 2020-2031
5.4.2 Asia Pacific Competent Cells Sales Value by Region (%), 2024 VS 2031
5.5 South America
5.5.1 South America Competent Cells Sales Value, 2020-2031
5.5.2 South America Competent Cells Sales Value by Country (%), 2024 VS 2031
5.6 Middle East & Africa
5.6.1 Middle East & Africa Competent Cells Sales Value, 2020-2031
5.6.2 Middle East & Africa Competent Cells Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Competent Cells Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Competent Cells Sales Value, 2020-2031
6.3 United States
6.3.1 United States Competent Cells Sales Value, 2020-2031
6.3.2 United States Competent Cells Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Competent Cells Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Competent Cells Sales Value, 2020-2031
6.4.2 Europe Competent Cells Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Competent Cells Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Competent Cells Sales Value, 2020-2031
6.5.2 China Competent Cells Sales Value by Type (%), 2024 VS 2031
6.5.3 China Competent Cells Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Competent Cells Sales Value, 2020-2031
6.6.2 Japan Competent Cells Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Competent Cells Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Competent Cells Sales Value, 2020-2031
6.7.2 South Korea Competent Cells Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Competent Cells Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Competent Cells Sales Value, 2020-2031
6.8.2 Southeast Asia Competent Cells Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Competent Cells Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Competent Cells Sales Value, 2020-2031
6.9.2 India Competent Cells Sales Value by Type (%), 2024 VS 2031
6.9.3 India Competent Cells Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Merck KGaA
7.1.1 Merck KGaA Profile
7.1.2 Merck KGaA Main Business
7.1.3 Merck KGaA Competent Cells Products, Services and Solutions
7.1.4 Merck KGaA Competent Cells Revenue (US$ Million) & (2020-2025)
7.1.5 Merck KGaA Recent Developments
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Profile
7.2.2 Thermo Fisher Scientific Main Business
7.2.3 Thermo Fisher Scientific Competent Cells Products, Services and Solutions
7.2.4 Thermo Fisher Scientific Competent Cells Revenue (US$ Million) & (2020-2025)
7.2.5 Thermo Fisher Scientific Recent Developments
7.3 Agilent Technologies
7.3.1 Agilent Technologies Profile
7.3.2 Agilent Technologies Main Business
7.3.3 Agilent Technologies Competent Cells Products, Services and Solutions
7.3.4 Agilent Technologies Competent Cells Revenue (US$ Million) & (2020-2025)
7.3.5 Agilent Technologies Recent Developments
7.4 Takara Bio
7.4.1 Takara Bio Profile
7.4.2 Takara Bio Main Business
7.4.3 Takara Bio Competent Cells Products, Services and Solutions
7.4.4 Takara Bio Competent Cells Revenue (US$ Million) & (2020-2025)
7.4.5 Takara Bio Recent Developments
7.5 Promega Corporation
7.5.1 Promega Corporation Profile
7.5.2 Promega Corporation Main Business
7.5.3 Promega Corporation Competent Cells Products, Services and Solutions
7.5.4 Promega Corporation Competent Cells Revenue (US$ Million) & (2020-2025)
7.5.5 Promega Corporation Recent Developments
7.6 Beijing TransGen Biotech
7.6.1 Beijing TransGen Biotech Profile
7.6.2 Beijing TransGen Biotech Main Business
7.6.3 Beijing TransGen Biotech Competent Cells Products, Services and Solutions
7.6.4 Beijing TransGen Biotech Competent Cells Revenue (US$ Million) & (2020-2025)
7.6.5 Beijing TransGen Biotech Recent Developments
7.7 GeneScript Corporation
7.7.1 GeneScript Corporation Profile
7.7.2 GeneScript Corporation Main Business
7.7.3 GeneScript Corporation Competent Cells Products, Services and Solutions
7.7.4 GeneScript Corporation Competent Cells Revenue (US$ Million) & (2020-2025)
7.7.5 GeneScript Corporation Recent Developments
7.8 Yeastern Biotech
7.8.1 Yeastern Biotech Profile
7.8.2 Yeastern Biotech Main Business
7.8.3 Yeastern Biotech Competent Cells Products, Services and Solutions
7.8.4 Yeastern Biotech Competent Cells Revenue (US$ Million) & (2020-2025)
7.8.5 Yeastern Biotech Recent Developments
7.9 New England Biolabs
7.9.1 New England Biolabs Profile
7.9.2 New England Biolabs Main Business
7.9.3 New England Biolabs Competent Cells Products, Services and Solutions
7.9.4 New England Biolabs Competent Cells Revenue (US$ Million) & (2020-2025)
7.9.5 New England Biolabs Recent Developments
7.10 QIAGEN N.V.
7.10.1 QIAGEN N.V. Profile
7.10.2 QIAGEN N.V. Main Business
7.10.3 QIAGEN N.V. Competent Cells Products, Services and Solutions
7.10.4 QIAGEN N.V. Competent Cells Revenue (US$ Million) & (2020-2025)
7.10.5 QIAGEN N.V. Recent Developments
7.11 OriGene Technologies
7.11.1 OriGene Technologies Profile
7.11.2 OriGene Technologies Main Business
7.11.3 OriGene Technologies Competent Cells Products, Services and Solutions
7.11.4 OriGene Technologies Competent Cells Revenue (US$ Million) & (2020-2025)
7.11.5 OriGene Technologies Recent Developments
7.12 Lucigen
7.12.1 Lucigen Profile
7.12.2 Lucigen Main Business
7.12.3 Lucigen Competent Cells Products, Services and Solutions
7.12.4 Lucigen Competent Cells Revenue (US$ Million) & (2020-2025)
7.12.5 Lucigen Recent Developments
7.13 Zymo Research
7.13.1 Zymo Research Profile
7.13.2 Zymo Research Main Business
7.13.3 Zymo Research Competent Cells Products, Services and Solutions
7.13.4 Zymo Research Competent Cells Revenue (US$ Million) & (2020-2025)
7.13.5 Zymo Research Recent Developments
7.14 Bio-Rad Laboratories
7.14.1 Bio-Rad Laboratories Profile
7.14.2 Bio-Rad Laboratories Main Business
7.14.3 Bio-Rad Laboratories Competent Cells Products, Services and Solutions
7.14.4 Bio-Rad Laboratories Competent Cells Revenue (US$ Million) & (2020-2025)
7.14.5 Bio-Rad Laboratories Recent Developments
7.15 Bioline
7.15.1 Bioline Profile
7.15.2 Bioline Main Business
7.15.3 Bioline Competent Cells Products, Services and Solutions
7.15.4 Bioline Competent Cells Revenue (US$ Million) & (2020-2025)
7.15.5 Bioline Recent Developments
7.16 Delphi Genetics
7.16.1 Delphi Genetics Profile
7.16.2 Delphi Genetics Main Business
7.16.3 Delphi Genetics Competent Cells Products, Services and Solutions
7.16.4 Delphi Genetics Competent Cells Revenue (US$ Million) & (2020-2025)
7.16.5 Delphi Genetics Recent Developments
7.17 IBA GmBH
7.17.1 IBA GmBH Profile
7.17.2 IBA GmBH Main Business
7.17.3 IBA GmBH Competent Cells Products, Services and Solutions
7.17.4 IBA GmBH Competent Cells Revenue (US$ Million) & (2020-2025)
7.17.5 IBA GmBH Recent Developments
7.18 Cell Applications
7.18.1 Cell Applications Profile
7.18.2 Cell Applications Main Business
7.18.3 Cell Applications Competent Cells Products, Services and Solutions
7.18.4 Cell Applications Competent Cells Revenue (US$ Million) & (2020-2025)
7.18.5 Cell Applications Recent Developments
7.19 BioDynamics Laboratory
7.19.1 BioDynamics Laboratory Profile
7.19.2 BioDynamics Laboratory Main Business
7.19.3 BioDynamics Laboratory Competent Cells Products, Services and Solutions
7.19.4 BioDynamics Laboratory Competent Cells Revenue (US$ Million) & (2020-2025)
7.19.5 BioDynamics Laboratory Recent Developments
7.20 Scarab Genomics
7.20.1 Scarab Genomics Profile
7.20.2 Scarab Genomics Main Business
7.20.3 Scarab Genomics Competent Cells Products, Services and Solutions
7.20.4 Scarab Genomics Competent Cells Revenue (US$ Million) & (2020-2025)
7.20.5 Scarab Genomics Recent Developments
7.21 GCC Biotech
7.21.1 GCC Biotech Profile
7.21.2 GCC Biotech Main Business
7.21.3 GCC Biotech Competent Cells Products, Services and Solutions
7.21.4 GCC Biotech Competent Cells Revenue (US$ Million) & (2020-2025)
7.21.5 GCC Biotech Recent Developments
7.22 SMOBIO Technology
7.22.1 SMOBIO Technology Profile
7.22.2 SMOBIO Technology Main Business
7.22.3 SMOBIO Technology Competent Cells Products, Services and Solutions
7.22.4 SMOBIO Technology Competent Cells Revenue (US$ Million) & (2020-2025)
7.22.5 SMOBIO Technology Recent Developments
7.23 Edge BioSystems
7.23.1 Edge BioSystems Profile
7.23.2 Edge BioSystems Main Business
7.23.3 Edge BioSystems Competent Cells Products, Services and Solutions
7.23.4 Edge BioSystems Competent Cells Revenue (US$ Million) & (2020-2025)
7.23.5 Edge BioSystems Recent Developments
8 Industry Chain Analysis
8.1 Competent Cells Industrial Chain
8.2 Competent Cells Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Competent Cells Sales Model
8.5.2 Sales Channel
8.5.3 Competent Cells Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
 Table 1. Competent Cells Market Trends
 Table 2. Competent Cells Market Drivers & Opportunity
 Table 3. Competent Cells Market Challenges
 Table 4. Competent Cells Market Restraints
 Table 5. Global Competent Cells Revenue by Company (2020-2025) & (US$ Million)
 Table 6. Global Competent Cells Revenue Market Share by Company (2020-2025)
 Table 7. Key Companies Competent Cells Manufacturing Base Distribution and Headquarters
 Table 8. Key Companies Competent Cells Product Type
 Table 9. Key Companies Time to Begin Mass Production of Competent Cells
 Table 10. Global Competent Cells Companies Market Concentration Ratio (CR5 and HHI)
 Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Competent Cells as of 2024)
 Table 12. Mergers & Acquisitions, Expansion Plans
 Table 13. Global Competent Cells Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
 Table 14. Global Competent Cells Sales Value by Type (2020-2025) & (US$ Million)
 Table 15. Global Competent Cells Sales Value by Type (2026-2031) & (US$ Million)
 Table 16. Global Competent Cells Sales Market Share in Value by Type (2020-2025)
 Table 17. Global Competent Cells Sales Market Share in Value by Type (2026-2031)
 Table 18. Global Competent Cells Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
 Table 19. Global Competent Cells Sales Value by Application (2020-2025) & (US$ Million)
 Table 20. Global Competent Cells Sales Value by Application (2026-2031) & (US$ Million)
 Table 21. Global Competent Cells Sales Market Share in Value by Application (2020-2025)
 Table 22. Global Competent Cells Sales Market Share in Value by Application (2026-2031)
 Table 23. Global Competent Cells Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
 Table 24. Global Competent Cells Sales Value by Region (2020-2025) & (US$ Million)
 Table 25. Global Competent Cells Sales Value by Region (2026-2031) & (US$ Million)
 Table 26. Global Competent Cells Sales Value by Region (2020-2025) & (%)
 Table 27. Global Competent Cells Sales Value by Region (2026-2031) & (%)
 Table 28. Key Countries/Regions Competent Cells Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
 Table 29. Key Countries/Regions Competent Cells Sales Value, (2020-2025) & (US$ Million)
 Table 30. Key Countries/Regions Competent Cells Sales Value, (2026-2031) & (US$ Million)
 Table 31. Merck KGaA Basic Information List
 Table 32. Merck KGaA Description and Business Overview
 Table 33. Merck KGaA Competent Cells Products, Services and Solutions
 Table 34. Revenue (US$ Million) in Competent Cells Business of Merck KGaA (2020-2025)
 Table 35. Merck KGaA Recent Developments
 Table 36. Thermo Fisher Scientific Basic Information List
 Table 37. Thermo Fisher Scientific Description and Business Overview
 Table 38. Thermo Fisher Scientific Competent Cells Products, Services and Solutions
 Table 39. Revenue (US$ Million) in Competent Cells Business of Thermo Fisher Scientific (2020-2025)
 Table 40. Thermo Fisher Scientific Recent Developments
 Table 41. Agilent Technologies Basic Information List
 Table 42. Agilent Technologies Description and Business Overview
 Table 43. Agilent Technologies Competent Cells Products, Services and Solutions
 Table 44. Revenue (US$ Million) in Competent Cells Business of Agilent Technologies (2020-2025)
 Table 45. Agilent Technologies Recent Developments
 Table 46. Takara Bio Basic Information List
 Table 47. Takara Bio Description and Business Overview
 Table 48. Takara Bio Competent Cells Products, Services and Solutions
 Table 49. Revenue (US$ Million) in Competent Cells Business of Takara Bio (2020-2025)
 Table 50. Takara Bio Recent Developments
 Table 51. Promega Corporation Basic Information List
 Table 52. Promega Corporation Description and Business Overview
 Table 53. Promega Corporation Competent Cells Products, Services and Solutions
 Table 54. Revenue (US$ Million) in Competent Cells Business of Promega Corporation (2020-2025)
 Table 55. Promega Corporation Recent Developments
 Table 56. Beijing TransGen Biotech Basic Information List
 Table 57. Beijing TransGen Biotech Description and Business Overview
 Table 58. Beijing TransGen Biotech Competent Cells Products, Services and Solutions
 Table 59. Revenue (US$ Million) in Competent Cells Business of Beijing TransGen Biotech (2020-2025)
 Table 60. Beijing TransGen Biotech Recent Developments
 Table 61. GeneScript Corporation Basic Information List
 Table 62. GeneScript Corporation Description and Business Overview
 Table 63. GeneScript Corporation Competent Cells Products, Services and Solutions
 Table 64. Revenue (US$ Million) in Competent Cells Business of GeneScript Corporation (2020-2025)
 Table 65. GeneScript Corporation Recent Developments
 Table 66. Yeastern Biotech Basic Information List
 Table 67. Yeastern Biotech Description and Business Overview
 Table 68. Yeastern Biotech Competent Cells Products, Services and Solutions
 Table 69. Revenue (US$ Million) in Competent Cells Business of Yeastern Biotech (2020-2025)
 Table 70. Yeastern Biotech Recent Developments
 Table 71. New England Biolabs Basic Information List
 Table 72. New England Biolabs Description and Business Overview
 Table 73. New England Biolabs Competent Cells Products, Services and Solutions
 Table 74. Revenue (US$ Million) in Competent Cells Business of New England Biolabs (2020-2025)
 Table 75. New England Biolabs Recent Developments
 Table 76. QIAGEN N.V. Basic Information List
 Table 77. QIAGEN N.V. Description and Business Overview
 Table 78. QIAGEN N.V. Competent Cells Products, Services and Solutions
 Table 79. Revenue (US$ Million) in Competent Cells Business of QIAGEN N.V. (2020-2025)
 Table 80. QIAGEN N.V. Recent Developments
 Table 81. OriGene Technologies Basic Information List
 Table 82. OriGene Technologies Description and Business Overview
 Table 83. OriGene Technologies Competent Cells Products, Services and Solutions
 Table 84. Revenue (US$ Million) in Competent Cells Business of OriGene Technologies (2020-2025)
 Table 85. OriGene Technologies Recent Developments
 Table 86. Lucigen Basic Information List
 Table 87. Lucigen Description and Business Overview
 Table 88. Lucigen Competent Cells Products, Services and Solutions
 Table 89. Revenue (US$ Million) in Competent Cells Business of Lucigen (2020-2025)
 Table 90. Lucigen Recent Developments
 Table 91. Zymo Research Basic Information List
 Table 92. Zymo Research Description and Business Overview
 Table 93. Zymo Research Competent Cells Products, Services and Solutions
 Table 94. Revenue (US$ Million) in Competent Cells Business of Zymo Research (2020-2025)
 Table 95. Zymo Research Recent Developments
 Table 96. Bio-Rad Laboratories Basic Information List
 Table 97. Bio-Rad Laboratories Description and Business Overview
 Table 98. Bio-Rad Laboratories Competent Cells Products, Services and Solutions
 Table 99. Revenue (US$ Million) in Competent Cells Business of Bio-Rad Laboratories (2020-2025)
 Table 100. Bio-Rad Laboratories Recent Developments
 Table 101. Bioline Basic Information List
 Table 102. Bioline Description and Business Overview
 Table 103. Bioline Competent Cells Products, Services and Solutions
 Table 104. Revenue (US$ Million) in Competent Cells Business of Bioline (2020-2025)
 Table 105. Bioline Recent Developments
 Table 106. Delphi Genetics Basic Information List
 Table 107. Delphi Genetics Description and Business Overview
 Table 108. Delphi Genetics Competent Cells Products, Services and Solutions
 Table 109. Revenue (US$ Million) in Competent Cells Business of Delphi Genetics (2020-2025)
 Table 110. Delphi Genetics Recent Developments
 Table 111. IBA GmBH Basic Information List
 Table 112. IBA GmBH Description and Business Overview
 Table 113. IBA GmBH Competent Cells Products, Services and Solutions
 Table 114. Revenue (US$ Million) in Competent Cells Business of IBA GmBH (2020-2025)
 Table 115. IBA GmBH Recent Developments
 Table 116. Cell Applications Basic Information List
 Table 117. Cell Applications Description and Business Overview
 Table 118. Cell Applications Competent Cells Products, Services and Solutions
 Table 119. Revenue (US$ Million) in Competent Cells Business of Cell Applications (2020-2025)
 Table 120. Cell Applications Recent Developments
 Table 121. BioDynamics Laboratory Basic Information List
 Table 122. BioDynamics Laboratory Description and Business Overview
 Table 123. BioDynamics Laboratory Competent Cells Products, Services and Solutions
 Table 124. Revenue (US$ Million) in Competent Cells Business of BioDynamics Laboratory (2020-2025)
 Table 125. BioDynamics Laboratory Recent Developments
 Table 126. Scarab Genomics Basic Information List
 Table 127. Scarab Genomics Description and Business Overview
 Table 128. Scarab Genomics Competent Cells Products, Services and Solutions
 Table 129. Revenue (US$ Million) in Competent Cells Business of Scarab Genomics (2020-2025)
 Table 130. Scarab Genomics Recent Developments
 Table 131. GCC Biotech Basic Information List
 Table 132. GCC Biotech Description and Business Overview
 Table 133. GCC Biotech Competent Cells Products, Services and Solutions
 Table 134. Revenue (US$ Million) in Competent Cells Business of GCC Biotech (2020-2025)
 Table 135. GCC Biotech Recent Developments
 Table 136. SMOBIO Technology Basic Information List
 Table 137. SMOBIO Technology Description and Business Overview
 Table 138. SMOBIO Technology Competent Cells Products, Services and Solutions
 Table 139. Revenue (US$ Million) in Competent Cells Business of SMOBIO Technology (2020-2025)
 Table 140. SMOBIO Technology Recent Developments
 Table 141. Edge BioSystems Basic Information List
 Table 142. Edge BioSystems Description and Business Overview
 Table 143. Edge BioSystems Competent Cells Products, Services and Solutions
 Table 144. Revenue (US$ Million) in Competent Cells Business of Edge BioSystems (2020-2025)
 Table 145. Edge BioSystems Recent Developments
 Table 146. Key Raw Materials Lists
 Table 147. Raw Materials Key Suppliers Lists
 Table 148. Competent Cells Downstream Customers
 Table 149. Competent Cells Distributors List
 Table 150. Research Programs/Design for This Report
 Table 151. Key Data Information from Secondary Sources
 Table 152. Key Data Information from Primary Sources
 Table 153. Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. Competent Cells Product Picture
 Figure 2. Global Competent Cells Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Global Competent Cells Sales Value (2020-2031) & (US$ Million)
 Figure 4. Competent Cells Report Years Considered
 Figure 5. Global Competent Cells Players Revenue Ranking (2024) & (US$ Million)
 Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Competent Cells Revenue in 2024
 Figure 7. Competent Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 8. Chemically Competent Cells Picture
 Figure 9. Electrocompetent Cells Picture
 Figure 10. Global Competent Cells Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 11. Global Competent Cells Sales Value Market Share by Type, 2024 & 2031
 Figure 12. Product Picture of Subcloning & Routine Cloning
 Figure 13. Product Picture of Phage Display Library Construction
 Figure 14. Product Picture of Toxic/Unstable DNA Cloning
 Figure 15. Product Picture of High-Throughput Cloning
 Figure 16. Product Picture of Protein Expression
 Figure 17. Product Picture of Mutagenesis
 Figure 18. Product Picture of Single-Stranded DNA Production
 Figure 19. Product Picture of Bacmid Creation
 Figure 20. Product Picture of Cre-Lox Recombination (PIR1/PIR2)
 Figure 21. Global Competent Cells Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 22. Global Competent Cells Sales Value Market Share by Application, 2024 & 2031
 Figure 23. North America Competent Cells Sales Value (2020-2031) & (US$ Million)
 Figure 24. North America Competent Cells Sales Value by Country (%), 2024 VS 2031
 Figure 25. Europe Competent Cells Sales Value, (2020-2031) & (US$ Million)
 Figure 26. Europe Competent Cells Sales Value by Country (%), 2024 VS 2031
 Figure 27. Asia Pacific Competent Cells Sales Value, (2020-2031) & (US$ Million)
 Figure 28. Asia Pacific Competent Cells Sales Value by Region (%), 2024 VS 2031
 Figure 29. South America Competent Cells Sales Value, (2020-2031) & (US$ Million)
 Figure 30. South America Competent Cells Sales Value by Country (%), 2024 VS 2031
 Figure 31. Middle East & Africa Competent Cells Sales Value, (2020-2031) & (US$ Million)
 Figure 32. Middle East & Africa Competent Cells Sales Value by Country (%), 2024 VS 2031
 Figure 33. Key Countries/Regions Competent Cells Sales Value (%), (2020-2031)
 Figure 34. United States Competent Cells Sales Value, (2020-2031) & (US$ Million)
 Figure 35. United States Competent Cells Sales Value by Type (%), 2024 VS 2031
 Figure 36. United States Competent Cells Sales Value by Application (%), 2024 VS 2031
 Figure 37. Europe Competent Cells Sales Value, (2020-2031) & (US$ Million)
 Figure 38. Europe Competent Cells Sales Value by Type (%), 2024 VS 2031
 Figure 39. Europe Competent Cells Sales Value by Application (%), 2024 VS 2031
 Figure 40. China Competent Cells Sales Value, (2020-2031) & (US$ Million)
 Figure 41. China Competent Cells Sales Value by Type (%), 2024 VS 2031
 Figure 42. China Competent Cells Sales Value by Application (%), 2024 VS 2031
 Figure 43. Japan Competent Cells Sales Value, (2020-2031) & (US$ Million)
 Figure 44. Japan Competent Cells Sales Value by Type (%), 2024 VS 2031
 Figure 45. Japan Competent Cells Sales Value by Application (%), 2024 VS 2031
 Figure 46. South Korea Competent Cells Sales Value, (2020-2031) & (US$ Million)
 Figure 47. South Korea Competent Cells Sales Value by Type (%), 2024 VS 2031
 Figure 48. South Korea Competent Cells Sales Value by Application (%), 2024 VS 2031
 Figure 49. Southeast Asia Competent Cells Sales Value, (2020-2031) & (US$ Million)
 Figure 50. Southeast Asia Competent Cells Sales Value by Type (%), 2024 VS 2031
 Figure 51. Southeast Asia Competent Cells Sales Value by Application (%), 2024 VS 2031
 Figure 52. India Competent Cells Sales Value, (2020-2031) & (US$ Million)
 Figure 53. India Competent Cells Sales Value by Type (%), 2024 VS 2031
 Figure 54. India Competent Cells Sales Value by Application (%), 2024 VS 2031
 Figure 55. Competent Cells Industrial Chain
 Figure 56. Competent Cells Manufacturing Cost Structure
 Figure 57. Channels of Distribution (Direct Sales, and Distribution)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

RELATED REPORTS

Global Salt Active Nuclease Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6W17226
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Ecology Products Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29H6022
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Robotics Paint Booth Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3R7922
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Parietal Bone Model Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34V19460
Fri Sep 12 00:00:00 UTC 2025

Add to Cart